We are live on ! Find out more
BFO

Boston Family Office Portfolio holdings

AUM $1.5B
1-Year Est. Return 11.68%
This Fund
S&P 500
This Quarter Est. Return
+3.78%
1 Year Est. Return
+11.68%
3 Year Est. Return
+44.44%
5 Year Est. Return
+55.04%
10 Year Est. Return
+251.5%
AUM
$880M
AUM Growth
+$35.6M
Cap. Flow
+$8.23M
Cap. Flow %
0.93%
Top 10 Hldgs %
20.56%
Holding
262
New
9
Increased
83
Reduced
85
Closed
5

Top Buys

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$3.55M
2
DD icon
DuPont de Nemours
DD
+$2.56M
3
KMI icon
Kinder Morgan
KMI
+$1.45M
4
NKE icon
Nike
NKE
+$922K
5
TEL icon
TE Connectivity
TEL
+$875K

Top Sells

Rank Stock Value
1
BKU icon
Bankunited
BKU
+$3.9M
2
DD
Du Pont De Nemours E I
DD
+$2.62M
3
AKAM icon
Akamai
AKAM
+$1.54M
4
WY icon
Weyerhaeuser
WY
+$856K
5
SLB icon
SLB Ltd
SLB
+$525K

Sector Composition

Rank Sector Weight
1 Healthcare 17.47%
2 Industrials 13.39%
3 Technology 13.23%
4 Consumer Staples 9.96%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
51
LKQ Corp
LKQ
$5.68B
$6.03M 0.69%
167,602
-1,747
-1% -$59.5K
ABT icon
52
Abbott
ABT
$183B
$5.91M 0.67%
110,704
+660
+0.6% +$33.1K
STRP
53
DELISTED
Straight Path Communications Inc.
STRP
$5.88M 0.67%
32,525
-75
-0.2% -$13.5K
V icon
54
Visa
V
$684B
$5.84M 0.66%
55,488
+2,495
+5% +$253K
THO icon
55
Thor Industries
THO
$3.9B
$5.83M 0.66%
46,286
+2,934
+7% +$316K
WY icon
56
Weyerhaeuser
WY
$18B
$5.66M 0.64%
166,325
-26,067
-14% -$856K
NWL icon
57
Newell Brands
NWL
$2.38B
$5.47M 0.62%
128,180
+72,680
+131% +$3.55M
TEL icon
58
TE Connectivity
TEL
$59.6B
$5.3M 0.6%
63,839
+10,885
+21% +$875K
WAB icon
59
Wabtec
WAB
$49.1B
$5.28M 0.6%
69,749
+232
+0.3% +$17.9K
CVX icon
60
Chevron
CVX
$392B
$5.01M 0.57%
42,681
+2,745
+7% +$300K
DHR icon
61
Danaher
DHR
$137B
$4.84M 0.55%
63,617
-2,956
-4% -$219K
GLNG icon
62
Golar LNG
GLNG
$5B
$4.79M 0.54%
211,644
+23,795
+13% +$523K
EEM icon
63
iShares MSCI Emerging Markets ETF
EEM
$28.9B
$4.65M 0.53%
103,682
-3
-0% -$132
RTN
64
DELISTED
Raytheon Company
RTN
$4.52M 0.51%
24,231
+2,795
+13% +$492K
SPGI icon
65
S&P Global
SPGI
$121B
$4.51M 0.51%
28,880
-330
-1% -$50.2K
PFE icon
66
Pfizer
PFE
$143B
$4.38M 0.5%
129,355
+57
+0% +$1.83K
TMO icon
67
Thermo Fisher Scientific
TMO
$213B
$4.33M 0.49%
22,867
+805
+4% +$146K
XRAY icon
68
Dentsply Sirona
XRAY
$2.68B
$4.19M 0.48%
70,125
-4,340
-6% -$258K
LECO icon
69
Lincoln Electric
LECO
$14.2B
$4.09M 0.47%
44,661
+20
+0% +$1.79K
MO icon
70
Altria Group
MO
$114B
$4.08M 0.46%
64,254
-2,427
-4% -$162K
KO icon
71
Coca-Cola
KO
$377B
$4.05M 0.46%
89,934
-411
-0.5% -$18.7K
CL icon
72
Colgate-Palmolive
CL
$73.1B
$4M 0.45%
54,847
-400
-0.7% -$28.8K
JPM icon
73
JPMorgan Chase
JPM
$935B
$3.93M 0.45%
41,163
+583
+1% +$53.8K
INTC icon
74
Intel
INTC
$455B
$3.73M 0.42%
97,827
-587
-0.6% -$20.9K
VEU icon
75
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
$3.67M 0.42%
69,691
+8,403
+14% +$435K

Similar funds

Boston Family Office's Q3 2017 Portfolio in Review

As of Q3 2017, Boston Family Office held 262 positions worth $880M, up 4.2% from $845M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Boston Family Office's Q3 2017 filing shows 9 new, 83 increased, 85 reduced and 5 closed positions. Its largest new stake was Bank OZK: 15,332 shares worth $737K. The largest sale was Bankunited, an estimated $3.9M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Industrials and Technology.

  • Boston Family Office's largest Q3 2017 buy was Bank OZK: 15,332 shares worth $737K.
  • Boston Family Office added most to Newell Brands in Q3 2017, an estimated $3.55M increase.
  • Boston Family Office's biggest Q3 2017 reduction was Bankunited, cutting an estimated $3.9M.
  • Boston Family Office fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.62M.
  • Boston Family Office's ten largest holdings make up 21% of its $880M portfolio in Q3 2017.
  • Boston Family Office opened 9 new positions and closed 5 in Q3 2017.
  • Boston Family Office's portfolio value rose 4.2% quarter-over-quarter to $880M.

Based on Boston Family Office's 13F filing for Q3 2017, filed 13 Nov 2017.